comprehensive -WSS

comprehensive

author：hotspot 2025-09-27 15:58:06 - browse：94474

A doctor climbs up a red ladder to a vine shaped like a DNA — biotech coverage from STAT — Adobe

Every morning, Victoria Rasberry gets up before 6 a.m., walks to the bedroom down the hall, and helps her 8-year-old daughter Addi slide into a set of contraptions that squeeze and suck out the thick mucus constantly threatening to choke her airways closed. She feeds Addi breakfast through a stomach tube and makes sure she has the right mix of the 28 different medications required to keep her free of pain, infections, and seizures. At some point, Rasberry’s five other children will wake up and start to get ready for school, including her youngest, Oliver. At 3-and-a-half years old, he’s a typical toddler — always running and giggling and getting into things. You would never know that he and Addi were born with the same mutation lurking in their DNA, a genetic glitch that causes a fatal neurodegenerative disease called metachromatic leukodystrophy, or MLD.

“When Addi was this age she had lost the ability to speak and was already using a ventilator to sleep at night,” Rasberry said. “It’s amazing to see how well Ollie is doing in comparison. And it’s all because of the gene therapy.”

Three years ago, when Ollie was just 6 months old, he and Victoria traveled from their home in Texas to Milan, to receive a gene therapy treatment that adds a healthy version of the defective gene into patients’ own stem cells. At the time, traveling abroad for the therapy, which is manufactured by Orchard Therapeutics and was approved in Europe in 2021, was the only option for families stricken by MLD. But soon it will be available in the U.S., too.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Cancer diagnosis changes perspective doctor, former hospital CEO

entertainment

leisure time

WSS

Ohio still needs to do more to protect the right to abortion

Healthy food access boosts outcomes in two studies

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

White House drug czar issues call for 'recovery

Weight loss drugs should be covered by insurers, AMA says

A letter from the executive editor: STAT UnitedHealth investigation

focus

comprehensive

knowledge

Hollywood unions extend contract negotiations for actors

White House drug czar issues call for 'recovery

Heart attack and stroke risk calculators need revising

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Activists slam private health insurers over coverage restrictions

Healthy food access boosts outcomes in two studies

Apple is now the first public company to be valued at $3 trillion

Study suggests Covid rebound is far more common with Paxlovid than without

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

knowledge

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Healthy food access boosts outcomes in two studies

A letter from the executive editor: STAT UnitedHealth investigation

Medical school prerequisites are outdated

Weight loss drugs should be covered by insurers, AMA says

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

hotspot

entertainment

leisure time

hotspot